Safety of quadrivalent human papillomavirus vaccine (Gardasil (R)) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013

Moro Pedro L.; Zheteyeva Yenlik; Lewis Paige; Shi Jing; Yue Xin; Museru Oidda I.; Broder Karen

首页> 外文期刊>Vaccine >Safety of quadrivalent human papillomavirus vaccine (Gardasil (R)) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013

【24h】

Safety of quadrivalent human papillomavirus vaccine (Gardasil (R)) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013

机译：四价人类乳头瘤病毒疫苗（Gardasil（R））在怀孕中的安全性：疫苗不良事件报告系统中非制造商报告中的不良事件，2006-2013年

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: In 2006, quadrivalent human papillomavirus (HPV4; Gardasil, Merck & Co., Inc.) vaccine was licensed in the US for use in females aged 9-26 years. HPV4 is not recommended during pregnancy; however, inadvertent administration during pregnancy may occur.

机译：背景：2006年，四价人乳头瘤病毒（HPV4; Gardasil，Merck＆Co.，Inc.）疫苗在美国获得许可，可用于9-26岁的女性。怀孕期间不建议使用HPV4;但是，怀孕期间可能会发生误用药的情况。

著录项

来源
《Vaccine》 |2015年第4期|共4页
作者
Moro Pedro L.; Zheteyeva Yenlik; Lewis Paige; Shi Jing; Yue Xin; Museru Oidda I.; Broder Karen;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Adverse events; Epidemiology; Quadrivalent human papillomavirus vaccine; Pregnancy; Surveillance; Vaccine safety;

机译：不良事件;流行病学;四价人乳头瘤病毒疫苗;妊娠;监测;疫苗安全性;

相似文献

外文文献
中文文献
专利

1. Safety of quadrivalent human papillomavirus vaccine (Gardasil (R)) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013 [J] . Moro Pedro L., Zheteyeva Yenlik, Lewis Paige, Vaccine . 2015,第4期

机译：四价人类乳头瘤病毒疫苗（Gardasil（R））在怀孕中的安全性：疫苗不良事件报告系统中非制造商报告中的不良事件，2006-2013年
2. Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017 [J] . Landazabal Claudia S., Moro Pedro L., Lewis Paige, Vaccine . 2019,第9期

机译：孕妇中9价人乳头瘤病毒疫苗疫苗疫苗疫苗疫苗疫苗疫苗疫苗疫苗疫苗疫苗：疫苗不良事件报告制度（VAERS），2014-2017中的不良事件报告
3. Post-licensure safety monitoring of quadrivalent human papillomavirus vaccine in the Vaccine Adverse Event Reporting System (VAERS), 2009-2015 [J] . Arana Jorge E., Harrington Theresa, Cano Maria, Vaccine . 2018,第13期

机译：疫苗不良事件报告系统（VAERS），2009-2015后二价管人乳头瘤病毒疫苗的持牌安全监测
4. Network Analysis of Possible Anaphylaxis Cases Reported to the US Vaccine Adverse Event Reporting System after H1N1 Influenza Vaccine [C] . Taxiarchis BOTSIS, Robert BALL Medical Informatics in Europe Conference. . 2011

机译：H1N1流感疫苗后，对美国疫苗不良事件报告系统的可能性过敏病症的网络分析
5. Signal Detection of Adverse Drug Reaction using the Adverse Event Reporting System: Literature Review and Novel Methods [D] . Pham, Minh H. 2018

机译：使用不良事件报告系统的不良药物反应的信号检测：文献综述和新方法
6. Safety of Quadrivalent Human Papillomavirus Vaccine (Gardasil®) in Pregnancy: Review of Non-manufacturer reports in the Vaccine Adverse Event Reporting System 2006 – 2013 [O] . Pedro L. Moro, Yenlik Zheteyeva, Paige Lewis, -1

机译：孕妇四价人乳头瘤病毒疫苗（Gardasil®）的安全性：疫苗不良事件报告系统中非制造商报告的审阅2006年– 2013年
7. Safety of quadrivalent human papillomavirus vaccine (Gardasil®) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006–2013 [O] . Pedro L. Moro, Yenlik Zheteyeva, Paige Lewis, 2015

机译：妊娠中四肢乳头瘤病毒疫苗（Gardasil®）的安全性：2006 - 2013年疫苗不良事件报告系统中非制造商报告中的不良事件
8. Morbidity and Mortality Weekly Report, January 24, 2003, Volume 52, Number SS-1. Surveillance for Safety After Immunization: Vaccine Adverse Event Reporting System (VAERS) - United States, 1991-2001 [R] . Hewitt, S. M. 2003

机译：发病率和死亡率每周报告，2003年1月24日，第52卷，ss-1号。免疫后安全性监测：疫苗不良事件报告系统（VaERs） - 美国，1991-2001

Safety of quadrivalent human papillomavirus vaccine (Gardasil (R)) in pregnancy: Adverse events among non-manufacturer reports in the Vaccine Adverse Event Reporting System, 2006-2013

摘要

著录项

相似文献

相关主题

期刊订阅